<li id="omoqo"></li>
  • <noscript id="omoqo"><kbd id="omoqo"></kbd></noscript>
  • <td id="omoqo"></td>
  • <option id="omoqo"><noscript id="omoqo"></noscript></option>
  • <noscript id="omoqo"><source id="omoqo"></source></noscript>
  • 發布時間:2019-04-28 20:42 原文鏈接: Protocolsforthepreparationoftumourcellsfors.c.injectionsinmice

    For the establishment of solid tumour in nude mice, tumour cells are treated in a sterile environment under a cell culturing hood. Disposable sterile plastic pipettes and flasks are used. Cultures are grown in a BB6220 incubator (Heraeus) at 37 °C and 6% CO2.

    The tumour models used in our laboratory are obtained by subcutaneous (s.c.) injection of the following cell lines in nude mice:

    C51 mouse colon adenocarcinoma

    FE-8 rat transformed fibroblasts

    F9 murine teratocarcinoma

    SKMEL-28 human melanoma

    Gelatin coating of flasks:

    F9 murine teratocarcinoma and SKMEL-28 human melanoma are cultured in flasks previously coated with 0.1% filtered gelatin solution (Sigma), overnight or 30 min. at 37 °C. Before usage, flasks are washed with sterile PBS.

    C51 mouse colon adenocarcinoma cells and FE-8 rat transformed fibroblasts are cultured in flasks with no gelatin coated surface.

    Media:

    Cell culturing medium for F9 mouse teratocarcinoma and SKMEL-28 human melanoma is composed of DMEM, 10% FCS and 1% antibiotic solution (penicillin, streptomycin, fungizone), all purchased form BioConcept.

    Cell culturing medium for C51 mouse colon adenocarcinoma cells and FE-8 rat transformed fibroblasts is composed of DMEM, 10% FCS, 1% antibiotic solution (penicillin, streptomycin, fungizone) and filtered glucose (0.37%).

    Flasks:

    Small-size flasks (25 cm2) are filled with 8-10 ml of medium.

    Medium-size flasks (75 cm2) are filled with 20 ml of medium.

    Large-size flasks (150 cm2) are filled with 40 ml of medium.

    Passaging cells:

    When cells are grown to confluency, they are washed with PBS and treated with a 0.05%-EDTA trypsine solution (BioConcept). Cells are detached from small-size flasks with 1 ml, from medium-size with 1.5 ml, from large-size flasks with 2.5 ml trypsine solution. The cell suspension is transferred into a 15-ml falcon tube and 10 ml medium added. Cells are pelleted by centrifugation (5 min, 1100 rpm), resuspended in fresh medium and divided into culture flasks with medium. Typically, cells are passaged every other day from one flask to a bigger-size flask, or from a large one to three large flasks.

    Preparation of Cryotubes:

    Typically, cryotubes are prepared from one large culture flask of confluent cells as follows. The medium is removed and the flask washed with 20 ml PBS. 2.5 ml trypsine are then aded and the flask moved gently to rinse all cells. The trypsinized cells are transferred into a 15 ml falcon tube and 10 ml medium added to block the reaction. After centrifugation (5 min., 1100 rpm), the supernatant is aspirated and new fresh medium added. After a second wash with PBS, cells are resuspended in 5 ml of cryotube-medium and aliquoted into 10 cryotubes. The medium used for the preparation of cryotubes is composed of DMEM medium, 20% FCS, 10% DMSO (alternatively, a 10% DMSO solution in FCS can be used for cryotube preparation). These tubes are frozen immediately at -80 0C for at least three days, and then transferred into a liquid nitrogen tank.

    Preparation of cells for subcutaneous injection in mice:

    From one large flask (150 cm2) with confluent cells, the medium is removed by aspiration. The flask is first washed with 20 ml PBS and then trypsinized with 2.5 ml trypsine solution. The trypsinized cells are transferred into a 15 ml falcon tube and 10 ml medium added. After centrifugation (5 min., 1100 rpm), cells are resuspended in sterile PBS (12 ml) and centrifuged again. The cell pellet is then resuspended in 500-600 μl of PBS and kept in ice, providing material for immdiate s.c. injection into 3-4 mice. Cell concentration before injection can be determined using a Neubauer-cytometer (Sigma). Approximately 106-107 cells are injected subcutaneously into 6-14 week-old female nude mice.


    相關文章

    中國期刊“黑神話”,比肩NCS!影響因子高達33.2

    日前,國產期刊TheInnovation獲得首個影響因子(IF=32.1),成為科睿唯安JCR綜合性期刊分類下排名僅次于《自然》(IF=64.8)和《科學》(IF=56.9)的期刊,并且這本期刊在目前......

    190億!賽默飛收購歐洲IVD巨頭

    近日,服務科學領域的全球領導者賽默飛世爾科技(以下簡稱賽默飛)宣布,在達成收購意向兩個月之后,賽默飛以28億美元、折合人民幣約190億元的價格,完成了對TheBindingSiteGroup的全現金收......

    施普林格·自然與TheLens達成合作

    11月15日,施普林格·自然和TheLens平臺宣布結成重要的合作伙伴關系,以更深入地揭示學術研究和數據如何能通過經濟和社會成效,加速推動創新的問題解決方式。通過將科學、投資和企業領域的開放數據更好地......

    “3CoinONE全新體驗氣袋進樣器”ANTOP獎進入專家評審階段

    萬物蓬勃的7月里迎來了2022年ANTOP獎的申報和評審工作。由島津企業管理(中國)有限公司申報的“3CoinONE全新體驗氣袋進樣器”ANTOP獎進入專家評審階段。獎項名稱:3CoinONE全新體驗......

    青源峰達太赫茲在國際頂級期刊《TrendsinBiotechnology》發文

    青島青源峰達太赫茲科技有限公司研發團隊在國際頂級期刊《TrendsinBiotechnology》(譯名:《生物技術趨勢》)在線發表題為“THzmedicalimaging:frominvitroto......

    科學家將人工智能技術成功用于蛋白質復合物結構預測

    蛋白質作為構成人體組織器官的支架和主要物質,在人體生命活動中起著重要作用。蛋白質的相互作用能產生許多效應,如形成特異底物作用通道、生成新的結合位點、失活、作用底物專一性和動力學變化等,細胞的代謝、信號......

    發力癌癥分子病理診斷,無錫臻和全資收購TissueofOrigin?

    2021年9月9日,無錫臻和生物科技有限公司(以下簡稱“臻和科技”)與美國VyantBio公司簽署TissueofOrigin?(以下簡稱“TOO?”)全球權益和ZL轉讓協議,全資收購這款唯一獲FDA......

    這3個雜志撤回中國學者249篇文章,包含上交、中山等名校

    2021年7月20日,JournalofCellularPhysiology及JournalofCellularBiochemistry同時撤回了中國學者49篇文章。從2019年開始,Journalo......

    firstinclass胃癌一線療法獲FDA突破性療法

    安進宣布,美國FDA授予其在研firstinclass單抗bemarituzumab突破性療法認定,與改良FOLFOX6化療方案(亞葉酸鈣、氟尿嘧啶和奧沙利鉑)聯用,一線治療FGFR2b過表達和HER......

    連看三大世界大學排名榜我國哪所大學是排名的“寵兒”?

    6月10日,QS教育集團正式發布了2021年世界大學排名,中國共有83所高校上榜,包括內地高校51所,港澳臺地區高校32所。中國大學的總體排名情況已經連續數年呈上升趨勢,今年再度刷新了榜單。大學排名,......

    <li id="omoqo"></li>
  • <noscript id="omoqo"><kbd id="omoqo"></kbd></noscript>
  • <td id="omoqo"></td>
  • <option id="omoqo"><noscript id="omoqo"></noscript></option>
  • <noscript id="omoqo"><source id="omoqo"></source></noscript>
  • 1v3多肉多车高校生活的玩视频